Dysport Approval History
- FDA approved: Yes (First approved April 29th, 2009)
- Brand name: Dysport
- Generic name: abobotulinumtoxinA
- Dosage form: Injection
- Company: Ipsen Biopharmaceuticals, Inc.
- Treatment for: Cervical Dystonia, Facial Wrinkles, Upper Limb Spasticity
Dysport (abobotulinumtoxinA) is an acetylcholine release inhibitor and neuromuscular blocking agent indicated for the treatment of cervical dystonia, for the temporary improvement in the appearance of moderate to severe glabellar lines, for the treatment of spasticity in adults, and the treatment of lower limb spasticity in pediatric patients.
Development History and FDA Approval Process for Dysport
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.